Mild therapeutic hypothermia (MTH) is used to lower the core body temperature of cardiac arrest (CA) patients to 32°C from 34°C to provide improved survival and neurologic outcomes after resuscitation from in-hospital or out-of-hospital CA. Despite the improved benefits of MTH, there are potentially unforeseen complications associated during management. Although the adverse effects are transient, the clinician should be aware of the associated complications when managing the patient receiving MTH. We aim to provide the medical community comprehensive information related to the potential complications of survivors of CA receiving MTH, as it is imperative for the clinician to understand the physiologic changes that take place in the patient receiving MTH and how to prepare for them and manage them if they do occur. We hope to provide information of how to manage these potential complications through both a review of the current literature and a reflection of our own experience.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1177/0885066613516416 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Fully Automated Assessment of Cardiac Chamber Volumes and Myocardial Mass on Non-Contrast Chest CT with a Deep Learning Model: Validation Against Cardiac MR.
Diagnostics (Basel)
December 2024
Department of Diagnostic and Interventional Radiology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Hugstetter Str. 55, 79106 Freiburg im Breisgau, Germany.
: To validate the automated quantification of cardiac chamber volumes and myocardial mass on non-contrast chest CT using cardiac MR (CMR) as a reference. : We retrospectively included 53 consecutive patients who received non-contrast chest CT and CMR within three weeks. A deep learning model created cardiac segmentations on axial soft-tissue reconstructions from CT, covering all four cardiac chambers and the left ventricular myocardium.
View Article and Find Full Text PDFIntra-individual Differences in Pericoronary Fat Attenuation Index Measurements Between Photon-counting and Energy-integrating Detector Computed Tomography.
Acad Radiol
December 2024
Department of Radiology and Radiological Science, Medical University of South Carolina, Charleston, SC (G.T., M.V-N., M.T.H., J.O., A.V-S., T.E., D.K.); Department of Diagnostic and Interventional Radiology, University Hospital Bonn, Bonn, Germany (J.A.L., D.Ku., A.I., D.K.); Quantitative Imaging Laboratory Bonn (QILaB), Bonn, Germany (J.A.L., D.Ku., A.I., D.K.).
Rationale And Objectives: The purpose of this study was to explore intra-individual differences in pericoronary adipose tissue (PCAT) fat attenuation index (FAI) between photon-counting detector (PCD)- and energy-integrating detector (EID)-CT.
Material And Methods: Patients were prospectively enrolled for a PCD-CT research scan within 30 days of EID-CT. Both acquisitions were reconstructed using a Qr36 kernel at 0.
Increased spatial coupling of integrin and collagen IV in the immunoresistant clear-cell renal-cell carcinoma tumor microenvironment.
Genome Biol
December 2024
Department of Genitourinary Oncology, Moffitt Cancer Center, Tampa, FL, 33612, USA.
Article Synopsis
- Immunotherapy has enhanced survival rates for patients with advanced clear cell renal cell carcinoma (ccRCC), but many patients still develop resistance to treatment.
- A study examined tumor samples from patients with both treatment-naïve and treatment-exposed ccRCC, revealing that tumors exposed to immunotherapy contained more immune cells (like CD8+ T cells and neutrophils) and showed significant changes in cellular markers.
- Key findings included increased expression of COL4A1 and ITGAV in the stroma of treated tumors, suggesting a need for further investigation into how these changes impact the tumor immune environment and potential new therapies.
Passive anti-amyloid β immunotherapy in Alzheimer's disease-opportunities and challenges.
Lancet
November 2024
Department of Psychiatry and Psychotherapy, Medical Faculty, University of Cologne, Cologne, Germany; German Center for Neurodegenerative Diseases, Bonn, Cologne, Germany; Excellence cluster on cellular stress response in aging associated disease, University of Cologne, Cologne, Germany.
Article Synopsis
- The paper discusses the introduction of a new type of immunotherapy for Alzheimer's, focusing on the implications of how, when, and who should be treated with it.
- It reviews key clinical trial results for three treatments: aducanumab, lecanemab, and donanemab, along with recommendations for patient selection and safety monitoring.
- The authors highlight the shift from syndrome-based care to early, biomarker-guided treatments for Alzheimer's, emphasizing the need for changes in healthcare infrastructure to support this approach while also promising potential benefits in slowing disease progression.
Doping-induced band-gap shrinkage to modify the electronic structure of MoS for organic wastewater management.
Dalton Trans
December 2024
Key Laboratory of Functional Materials Physics and Chemistry of the Ministry of Education, Jilin Normal University, Changchun, 130103, P. R. China.
Article Synopsis
- - MoS (molybdenum disulfide) is a promising material for sensing and environmental cleanup due to its large surface area and adjustable electronic properties, but it faces challenges like aggregation and complex electron-hole interactions that hinder its performance.
- - The study introduces a band-gap shrinkage strategy that enhances MoS's effectiveness for SERS (Surface-Enhanced Raman Spectroscopy) and photocatalytic applications, showing a significant SERS enhancement factor and stability over time, as well as impressive reusability.
- - Doping with ruthenium (Ru) improves charge transfer and sensitivity, allowing for a detection limit as low as 10 M for certain compounds and achieving a 99% degradation rate of pollutants under visible
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!